About PRECISION QUANTOMICS, INC.
Precision Quantomics develops next-generation proteomics-based assays and quantitative in vitro platforms to enhance drug candidate selection, reduce reliance on animal models, and forecast drug metabolism, transport, toxicity, and disease risk. Their tools support safer drug development and precision medicine.
Developing next-generation proteomics-based assaysCreating quantitative in vitro platformsEnhancing drug candidate selectionForecasting drug metabolism, transport, toxicity, and disease riskSupporting non-animal testing initiatives with New Approach Methodologies (NAMs)Providing expert support in ADMET studiesOffering customized proteomic solutions
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to PRECISION QUANTOMICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.